IDO1 and neoplasm: Certain boosting antibodies or tumor-targeting monoclonal antibodies (mAbs) can even inhibit the cytotoxic effect of NK and T cells by promoting the expression of PD-L1 and indoleamine 2, 3-dioxygenase (IDO).